Reuters logo
BRIEF-Uniqure announces FDA orphan drug designation for AMT-130 in huntington’s disease
October 6, 2017 / 11:06 AM / in 12 days

BRIEF-Uniqure announces FDA orphan drug designation for AMT-130 in huntington’s disease

Oct 6 (Reuters) - Uniqure NV:

* Uniqure announces FDA orphan drug designation for AMT-130 in huntington’s disease Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below